Global Med Technologies(R) to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
July 05 2007 - 10:00AM
PR Newswire (US)
DENVER, July 5 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. ("Global Med" or the "Company") (OTC:GLOB)
(BULLETIN BOARD: GLOB) , an international e-Health, medical
information technology company, will be presenting at the C.E.
Unterberg, Towbin Emerging Growth Opportunities Conference to be
held at the Mandarin Oriental Hotel located at the Time-Warner
Center in New York City. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Global
Med's Chairman and CEO, Mick Ruxin, M.D., will provide a Company
overview, along with an update on Global Med's current operations
and new developments, on Thursday, July 12th from 2:30 to 3:00 PM.
Time for questions and answers will follow the presentation.
Unterberg, Towbin will also arrange one-on-one meetings with
potential investors. For further information on the C.E. Unterberg,
Towbin Emerging Growth Opportunities Conference, please contact Ms.
Leigh Simons at Unterberg, Towbin at (212) 389-8127 or e-mail: .
About Global Med Technologies, Inc. Global Med Technologies, Inc.
is an international e-Health, medical information technology
company providing information management software products and
services to the healthcare industry. Its Wyndgate Technologies
division is a leading supplier of information management systems to
U.S. and international blood centers and hospital transfusion
centers. Each year, Wyndgate's products and services manage more
than eight million blood components, representing over 27% of the
U.S. blood supply. Wyndgate's products are being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the Donor Doc(TM) interactive donor health history
questionnaire, SafeTrace(R) donor management system, and the
SafeTrace Tx(R)* advanced transfusion management system provide
Vein-to- Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R),
Inc. CONTACT: Michael I. Ruxin, M.D., Chairman and CEO of Global
Med Technologies(R), Inc., +1-303-238-2000; or investors, Paul M.
Holm of H.L. Lanzet, +1-212-888-4570, , for Global Med
Technologies(R), Inc. Web site: http://www.globalmedtech.com/
http://www.wyndgate.com/ http://www.peoplemed.com/
Copyright